Skip to main content
. 2021 Oct 26;10(21):4967. doi: 10.3390/jcm10214967

Table 5.

Health-related quality of life according to the SRS-22r and EQ-VAS global health scores at baseline, within group changes from baseline to 6 months, and between group differences in changes from baseline to 6 months.

Baseline Within Group Changes from Baseline to 6 Months Between Group Differences in Changes between Baseline and 6 Months
Mean (SD) Mean Change (SD) p-Value Cohen´s d Main Effects F; p-Value; ηp2 Pairwise Comparison
Mean Difference (95% CI) p-Value
Negative Change = Worse Outcome
SRS-22r Function (1–5) 1.2; 0.298; 0.02 NA
NB 4.8 (0.2) −0.1 (0.3) 0.018 0.36
SSE 4.7 (0.3) −0.1 (0.4) 0.066
PA 4.7 (0.3) <−0.1 (0.3) 0.925
SRS-22r Pain (1–5) 0.4; 0.658; 0.01 NA
NB 4.7 (0.6) <−0.1 (0.4) 0.731
SSE 4.6 (0.6) <−0.1 (0.4) 0.486
PA 4.7 (0.6) <−0.1 (0.4) 0.943
SRS-22r Self-image (1–5) 1.8; 0.170; 0.03 NA
NB 4.1 (0.7) 0.1 (0.5) 0.367
SSE 4.2 (0.6) −0.1 (0.5) 0.101
PA 4.3 (0.5) −0.1 (0.5) 0.200
SRS-22r Mental health (1–5) 0.8; 0.437; 0.02 NA
NB 4.3 (0.6) −0.1 (0.4) 0.325
SSE 4.3 (0.5) −0.1 (0.6) 0.152
PA 4.3 (0.6) −0.2 (0.5) 0.009 0.33
SRS-22r Subscore (1–5) 0.9; 0.394; 0.02 NA
NB 4.5 (0.5) <−0.1 (0.2) 0.493
SSE 4.5 (0.4) −0.1 (0.3) 0.039 0.22
PA 4.5 (0.3) −0.1 (0.3) 0.057
SRS-22r Satisfaction (1–5) At 6 months only 2.7; 0.074; 0.05 NA
NB 3.9 (0.8)
SSE 3.5 (0.9)
PA 3.4 (1.1)
SRS-22r Total Score (1–5) At 6 months only 0.8; 0.460; 0.01 NA
NB 4.4 (0.5)
SSE 4.3 (0.5)
PA 4.3 (0.4)
EQ-VAS Global health (0–100) 0.2; 0.763; 0.01 NA
NB 88.2 (11.5) −2.6 (10.4) 0.133
SSE 88.0 (10.0) −3.2 (15.0) 0.197
PA 87.6 (10.6) −1.0 (12.2) 0.620

SRS-22r: The Scoliosis Research Society-22r; EQ-VAS: EuroQol Visual Analogue Scale; NB: hypercorrective Boston brace night shift; SSE: scoliosis-specific exercise; PA: adequate self-mediated physical activity. Bold = significant at p < 0.05; Cohen’s d estimate = effect size; ηp2 = partial eta squared. NA = not applicable.